CIOInsider India Magazine
.png){kind=logo}
Sameer Koul
Co-Founder & Customer Specialist
Generative AI Solutions providers are at the forefront of driving technological transformation, leveraging artificial intelligence to generate new, innovative solutions to real-world problems. These providers are reshaping healthcare, finance, retail, and manufacturing industries by creating AI models that can generate, predict, and automate tasks with impressive efficiency and accuracy. Through generative AI, companies can improve decision making, streamline operations, and even create new products or services, paving the way for a more innovative and efficient future. One such provider, Dashamlav AI Labs, has focused its expertise on transforming oncology care.
Dashamlav AI Labs was born from a collaborative vision to tackle real-world challenges in oncology. The idea first emerged during an insightful conversation over a cup of coffee with Dr. Kundan, an oncology pioneer with over 100 publications to his name. Dr. Kundan highlighted patients’ Clinical data issues for improving Patient outcomes, which led to the conceptualization of Dashamlav's AI-driven solution to improve oncology work flows.
As the idea developed, Dr. Andrew Miller, a seasoned expert in oncology, joined the team as an advisor and mentor, providing valuable insights into the complexities of oncology practices. Dr. Irfan, a radiation oncologist passionate about analytics, became an essential member, ensuring the solution's relevance in the medical field. The team also strengthened its techno -logical capabilities by bringing Alok Dwivedi, a UKbased software expert
with extensive experience in building secure and scalable software systems, on board.
Dashamlav AI Labs represents a powerful fusion of empathy, precision, and technological expertise, creating AI solutions that empower clinicians with actionable insights to improve patient care. The company is committed to bridging cutting-edge innovation with compassionate healthcare, trans- forming oncology practices across various healthcare settings. Let’s dive in to know more.
Our success is dedicated to our users and Collabo -rators, whose valuable inputs have been crucial to our progress
Tell about your flagship offerings and what are the value additions the clients can expect from your offerings?
Dashamlav AI Labs offers AI-driven solutions designed to improve oncology care. Our core product, OncFlow, is an GenAI Powered platform for clinical data acquisition and workflow management, streamlining processes and providing oncologists with actionable insights into decision-making and optimized treatment plans.
We also offer MedCompass, a real-time collaboration tool that enhances communication among healthcare professionals, fostering efficient teamwork. PulseDash is our patient engagement tool, designed as a Patient-Reported Outcome Measures (PROM) tool, improving patient involvement throughout their treatment journey.
Clients can expect significant value from our offerings, including enhanced decision-making, improved operational efficiency, scalability, and a significant reduction in medical staff’s cognitive load. These solutions streamline workflows and contribute to better patient outcomes and experiences, empowering healthcare providers to deliver more precise and personalized care.
Can you share a recent challenging case study that demonstrates the success of your company's solutions in achieving positive outcomes?
A recent case study highlights the effectiveness of our solutions in driving positive outcomes. One of our users, tasked with analyzing patient data from the past year for a conference presentation, faced the daunting challenge of extracting, analyzing, and summarizing large volumes of information. This time-intensive task, typically taking weeks to months, was completed in under an hour using OncoBot, our AI-powered search and analysis tool. This efficiency saved significant time and allowed the user to focus on delivering impactful insights at the conference, demonstrating the value of our AI-driven solutions in streamlining complex workflows and enhancing productivity.
Can you briefly describe the workforce that drives the company's success?
Our success is dedicated to our users and collaborators, whose valuable inputs have been crucial to our progress. Internally, we draw strength from our advisors, who bring extensive domain knowledge and expertise, and a young, dynamic, and enthusiastic team of developers and testers. I would like to thank Dr. Miller, Dr. Kundan, Dr. Irfan, and Alok for their significant contributions to our knowledge, helping us carve a unique niche in the intersection of oncology and technology.
What role does Dashamlav AI Labs envision for itself in the near future, and what impact does it aim to have on the market?
Dashamlav AI Labs envisions a future where AI driven solutions are central to oncology care, improving treatment strategies, patient outcomes, and overall experiences. We aim to strengthen our position as a trusted partner in clinical decision-making, offering scalable, data driven tools that enhance diagnostic accuracy, optimize workflows, and deliver improved patient outcomes & experience. Our objectives include improving decision-making processes, driving innovation in patient engagement, and enhancing both clinical and operational outcomes - all while ensuring its cost effectiveness & RoIs.
